BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  Orchard Therapeutics to Present at Multiple Investor Conferences in September 2021

  Orchard Therapeutics today announced that members of the management team will present and be available for one-on-one meetings at the following investor conferences: Goldman Sachs 11th Annual Biotech Symposium on September 7, 2021

  September 1, 2021

   · 

  2 min read
• Business

  Brickell Biotech Acquires Exclusive Rights to Phase 1-Ready DYRK1A Inhibitor Program and Novel Platform Targeting Autoimmune and Inflammatory Diseases

  Brickell Biotech today announced it has entered into a definitive agreement with Voronoi Inc.

  September 1, 2021

   · 

  10 min read
• FDA

  Intelivation Technologies received FDA approval for the Golden Isles Pedicle Screw System™

  Intelivation Technologies announced today that they have achieved FDA 510(k) Clearance of the Golden Isles Pedicle Screw System™ .

  September 1, 2021

   · 

  1 min read
• Drug Development

  Lumen Bioscience Launches Phase 1 Trial of Oral Biologic Drug for Preventing C. difficile Infection Recurrence

  Lumen Bioscience today announced the start of a Phase 1 trial of LMN-Cdiff01, an orally delivered investigational biologic for treatment and prevention of recurrent C. difficile infection (CDI).

  September 1, 2021

   · 

  3 min read
• Genetown

  Bicycle Therapeutics to Participate in Upcoming Investor Conferences

  Bicycle Therapeutics plc today announced that management will participate in the following investor conferences in September: Goldman Sachs Eleventh Annual Biotech Symposium on Tuesday, September 7, 2021

  September 1, 2021

   · 

  2 min read
• Biotech Bay

  Asher Bio Closes $108 Million Series B Financing

  Asher Biotherapeutics today announced the closing of an oversubscribed Series B financing, which raised $108 million.

  September 1, 2021

   · 

  5 min read
• BioMidwest

  Exicure to Participate in Upcoming Investor Conferences

  Exicure , Inc. today announced participation in the following investor conferences during the month of September: Citi’s 16th Annual Biopharma Conference 2021 One-on-one meetings September 8-10, 2021

  September 1, 2021

   · 

  1 min read
• Business

  Ribon Therapeutics Announces Key Management Promotions

  Ribon Therapeutics today announced the promotions of Heike Keilhack, Ph.D., to Chief Scientific Officer and Kevin Kuntz, Ph.D., to Chief Drug Development Officer.

  September 1, 2021

   · 

  3 min read
• Genetown

  Keystone Dental Announces Completion of $25 Million Financing to Accelerate Growth of Dental Implant and Digital Dentistry Portfolio

  Keystone Dental Inc., the largest independent dental implant company operating in North America, announced a $25 million financing.

  September 1, 2021

   · 

  2 min read
• Business

  ProMIS Neurosciences appoints accomplished biotechnology executive, Josh Mandel-Brehm, to its Board of Directors

  ProMIS Neurosciences, Inc. today announced the appointment of Josh Mandel-Brehm to its Board of Directors with immediate effect.

  September 1, 2021

   · 

  4 min read